Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation (Q39703952)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation |
scientific article |
Statements
1 reference
Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation (English)
1 reference
Nancy L Cho
1 reference
Chi-Iou Lin
1 reference
Edward E Whang
1 reference
Adelaide M Carothers
1 reference
Francis D Moore
1 reference
Daniel T Ruan
1 reference
1 June 2010
1 reference
Identifiers
1 reference